PATENT CLAIM ANALYSIS

Application Number: 15780134
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "341000"]

Abstract:
The present invention provides a compound of Formula I and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

Claim (Index 10):
A method for inhibiting thrombus formation in blood or treating thrombus formation in blood comprising administering a composition of  claim 9  to a mammal in need of thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.44737
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15771538', '15116576', '15329609', '15312839', '15329634']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7909413841087457
- 35 USC 102 Novelty (BERT): 0.5769194389135895
- Combined Prediction Score: 0.7695391895892301
- Mean Citation Score: 442.1717540000001
- Max Citation Score: 450.88834
- Similarity Product: 441.485086235733

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test